Guardian Pharmacy Recalls B-Complex Due to Lack of Sterility Assurance
Guardian Pharmacy Services is recalling B-Complex products in 100 mL bags and vials due to a lack of sterility assurance. The affected units were distributed in Texas.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility assurance in a compounded drug is rated as Severe (4).
Plain-English summary
Guardian Pharmacy Services is recalling B-Complex products, which are prescription-only medications packaged in 100 mL bags and 100 mL MDV vials. The recall was initiated because of a lack of sterility assurance in the compounded products.
The affected products were distributed in Texas. The specific lots involved are 58572:42 with a use-by date of 05/29/2018, and 58768:42 with a use-by date of 06/20/2018. The total quantity recalled is 2,600 units.
Consumers and healthcare providers should stop using the affected B-Complex products and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- B-Complex Rx only. packaged in a) 100 mL bag b) 100 ml MDV vial. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247
- Manufacturer
- Guardian Pharmacy Services
- Category
- Drug — Compounded Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lots: a) 58572:42 Use By: 05/29/2018 b) 58768:42 Use By: 06/20/2018
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 23 recalled by Guardian Pharmacy Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Guardian Pharmacy Services
See all →- SevereGuardian Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Phenol 6% Injection Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Morphine Sulfate CADD Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Cefazolin Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Glycopyrrolate Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- HighIC B Complex Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereGreen Valley Drugs Recalls B-Complex Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereB-Complex Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- CriticalGuardian Pharmacy Recalls Lidocaine Syringes Due to Failed Sterility Test
FDA (Drugs) · 2016-12-28
- SevereBella Pharmaceuticals Recalls B-Complex Vials Due to Sterility Concerns
FDA (Drugs) · 2017-09-20
- SevereRXQ Compounding Recalls Vitamin B Complex 100 Due to Sterility Concerns
FDA (Drugs) · 2019-08-14